Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 may harm male fertility and damage the reproductive system.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Social media data can help track and predict COVID-19 symptoms and trends.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

COVID-19 vaccines do not increase the risk of alopecia areata.

COVID-19 can cause skin problems in children.